{"nct_id":"NCT00441610","title":"An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor","status":"COMPLETED","status_verified_date":"2012-04","start_date":"2007-01","start_date_type":null,"primary_completion_date":"2009-09","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE1"],"tickers":["NVS"]}